Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF

Translate this page into:

Letters to the Editor - Letter in Response to Previously Published Articles
2016:82:4;417-418
doi: 10.4103/0378-6323.182970
PMID: 27279302

Immunotherapy or not? The mystery deepens

Shaurya Rohatgi1 , Amit Shivaji Kerure2 , Satish Udare1 , Hemangi Rajiv Jerajani1
1 Department of Dermatology, Venereology and Leprosy, MGM Medical College and Hospital, Navi Mumbai, Maharashtra, India
2 Consultant Dermatologist, Dr. Amit Kerure Skin Clinic, Navi Mumbai, Maharashtra, India

Correspondence Address:
Shaurya Rohatgi
Department of Dermatology, Venereology and Leprosy, MGM Medical College and Hospital, Navi Mumbai, Maharashtra
India
How to cite this article:
Rohatgi S, Kerure AS, Udare S, Jerajani HR. Immunotherapy or not? The mystery deepens. Indian J Dermatol Venereol Leprol 2016;82:417-418
Copyright: (C)2016 Indian Journal of Dermatology, Venereology, and Leprology

Sir,

This is with reference to the study by Saoji et al. on immunotherapy of warts with purified protein derivative (PPD).[1] Although it is a carefully executed study; in our view, the use of the term “immunotherapy” is an inappropriate description for the method employed by the authors. We understand that they achieved good clearance rates using the methods described in the report but injecting PPD into multiple lesions defies the true meaning of immunotherapy.

In the section methods, they write “2.5 tuberculin units (TU) of PPD was injected into each lesion.[1] In case of multiple lesions, a maximum of 10 representative lesions covering all the sites and a maximum of 25 TU of PPD was injected during each session.” Immunotherapy is defined as treatment designed to produce immunity to a disease or enhance the resistance of the immune system to an active disease process. It involves injecting a specific dose of antigen at specific intervals in order to sensitize the immune system. Vaccination is also a type of immunotherapy and all vaccines are administered as a single dose, not as multiple doses throughout the body. Booster doses are given for many vaccines but that is not to be considered as multiple doses. By that principle, immunotherapy for warts should not be given into all or multiple lesions, but only one lesion.

We are not suggesting that injecting tuberculin or any other form of immunotherapy into multiple warts in the same patient is wrong. The authors have shown that it works well but this practice may lead to confusion for clinicians and future researchers attempting this modality of treatment. It may create doubt as to how many warts to inject and how much to inject in each patient. Therefore, the exact and effective dose of the antigen will not be recognized and proper treatment guidelines cannot be formulated. Moreover, it has been shown in multiple studies that immunotherapy works well even if we inject the agent in only one lesion.[2],[3],[4],[5] The authors of this letter have conducted a similar study in which a specific amount of PPD (0.1 ml) was injected in the same target wart with up to 100% results.[5] Therefore, we suggest that following this protocol will maintain uniformity and may avoid confusion for future studies as well as clinical practice.

Immunotherapy is a new treatment modality for warts and many studies are reporting its beneficial effect. However, recent British guidelines state that there is no robust evidence to support the use of intralesional immunotherapy.[6] This recommendation stems from the fact that randomized controlled trials are lacking. Most studies do not have a control group and simply mention cure rates without comparison to either control or another traditional modality of treatment. Nofal and Nofal included saline as control in their comparative study for evaluating the efficacy of intralesional measles, mumps and rubella vaccine[2] Interestingly, complete or partial response was also seen in the saline group (27.5% and 15%, respectively). The response in the saline group could be related to some amount of tissue autoinoculation occurring during intralesional injection. The study protocol dictated injection into the single largest wart for all patients. But if we increase the number of warts to be injected, this would increase the chance of autoinoculation of wart tissue and thereby increase the clearance rates of either group. Therefore, while it may be useful for boosting response rates, this is not true immunotherapy but simply manipulation of the lesion.

There is another important precaution to be taken while administering tuberculin which may have been ignored. The authors mention that history of tuberculosis was not considered as an exclusion criterion. But, according to the tuberculin package insert, PPD should be administered with caution, or not at all, in persons with documented active tuberculosis or documented treatment in the past because of the severity of reactions (e.g., vesiculation, ulceration or necrosis) that may occur at the test site.[7] This may be of additional concern in a country like India where tuberculosis is endemic and frequent. Moreover, if we inject multiple lesions, the chances of a severe local reaction may increase further.

In conclusion, this study does not concretely define the amount of PPD required and the number of lesions to be injected. In addition, there is uncertainty about how to decide the amount of PPD required in relation to the extent of the disease, whether to inject the same dosage in subsequent sittings and what to do if numbers of lesions reduce. More studies are needed to resolve these ambiguities.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References
1.
Saoji V, Lade NR, Gadegone R, Bhat A. Immunotherapy using purified protein derivative in the treatment of warts: An open uncontrolled trial. Indian J Dermatol Venereol Leprol 2016;82:42-6.
[Google Scholar]
2.
Nofal A, Nofal E. Intralesional immunotherapy of common warts: Successful treatment with mumps, measles and rubella vaccine. J Eur Acad Dermatol Venereol 2010;24:1166-70.
[Google Scholar]
3.
Shaheen MA, Salem SA, Fouad DA, El-Fatah AA. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: A comparative clinical and immunological study. Dermatol Ther 2015;28:194-200.
[Google Scholar]
4.
Abd-Elazeim FM, Mohammed GF, Fathy A, Mohamed RW. Evaluation of IL-12 serum level in patients with recalcitrant multiple common warts, treated by intralesional tuberculin antigen. J Dermatolog Treat 2014;25:264-7.
[Google Scholar]
5.
Kerure AS, Nath AK, Oudeacoumar P. Intralesional immunotherapy with tuberculin purified protein derivative for verruca: A study from a teaching hospital in South India. Indian J Dermatol Venereol Leprol 2016;Feb 8.doi: 10.4103/0378-6323.175910.[Epub ahead of print]
[Google Scholar]
6.
Sterling JC, Gibbs S, Haque Hussain SS, Mohd Mustapa MF, Handfield-Jones SE. British Association of Dermatologists' guidelines for the management of cutaneous warts 2014. Br J Dermatol 2014;171:696-712.
[Google Scholar]
7.
Tubersol®: Tuberculin Purified Protein Derivative (Mantoux). Toronto, Ontario, Canada: SanofiPasteur Limited; 2013. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM114924.pdf [Last accessed on 2016 Feb 20].
[Google Scholar]

Fulltext Views
2,409

PDF downloads
1,264
Show Sections